Comparación de la actividad de 2 factores estimuladores de colonias de granulocitos de producción nacional: Hebervital y Leukocim

Socarrás Ferrer, Bertha Beatriz; Macías Abraham, Consuelo; del Valle Pérez, Lázaro; Marsán Suárez, Vianed; Vergara Castellanos, Janet; Lam Díaz, Rosa María; González Iglesias, Ana Iris; Matamoros, María de los Angeles; Infante Cristiá, Ena; Guerra Segura, Osmel; Mulens Arias, Vladimir; Hernández Ramírez, Porfírio.
Rev. cuba. hematol. inmunol. hemoter ; 27(4): 429-434, oct.-dic. 2011.
Artículo en Español | LILACS | ID: lil-615372

Documentos relacionados

  1. [Effect of Intrauterine Perfusion of Granulocyte Colony-Stimulating Factor on Endometrium and Blood Flow Parameters in Patients With Thin Endometrium: A Prospective Controlled Clinical Trial].
  2. Comparación de la actividad de 2 factores estimuladores de colonias de granulocitos de producción nacional: Hebervital y Leukocim
  3. The effects of lower CD34 yields after lowe dose G-CSF induction on long-term autologous stem cell transplantation outcome: A single center study.
  4. Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
  5. Granulocyte colony stimulating factor therapy for acute myocardial infarction.
  6. Comparison of two autologous hematopoietic stem cell mobilization strategies in patients with multiple myeloma: CE plus G-CSF versus G-CSF only: A single-center retrospective analysis.
  7. The value of G-CSF in women experienced at least one implantation failure: a systematic review and meta-analysis.
  8. A systematic literature review of the efficacy, effectiveness, and safety of filgrastim.
  9. Impact of cladribine, cytarabine, and G-CSF (CLAG) as a bridging therapy prior to allogeneic hematopoietic stem cell transplantation in relapsed or refractory acute myeloid leukemia.
  10. GENESIS: Phase III trial evaluating BL-8040 + G-CSF to mobilize hematopoietic cells for autologous transplant in myeloma.